Cargando…
Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer
The bioactivity of matrix metalloproteinases was studied in tissues from colorectal cancer patients by means of both quantitative gelatin zymography and a fluorometric activity assay. Next to paired samples of tumour tissue and distant normal mucosa (n=73), transitional tissue was analysed from a li...
Autores principales: | Waas, E T, Lomme, R M L M, DeGroot, J, Wobbes, Th, Hendriks, T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375422/ https://www.ncbi.nlm.nih.gov/pubmed/12085179 http://dx.doi.org/10.1038/sj.bjc.6600366 |
Ejemplares similares
-
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer
por: Tanioka, Y, et al.
Publicado: (2003) -
Matrix metalloproteinases 2 and 9 (gelatinases A and B) expression in malignant mesothelioma and benign pleura
por: Edwards, J G, et al.
Publicado: (2003) -
Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma
por: Talvensaari-Mattila, A, et al.
Publicado: (2003) -
Tissue inhibitor of metalloproteinase-1 stimulates proliferation of human cancer cells by inhibiting a metalloproteinase
por: Porter, J F, et al.
Publicado: (2004) -
Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy
por: Hanke, B, et al.
Publicado: (2003)